Analysis of the potential relationship between COVID-19 and Behcet's disease using transcriptome data.

Area of Science:

• Genomics and Bioinformatics
• Immunology and Infectious Diseases
• Rheumatology and Autoimmune Disorders

Background:

• Behcet's disease (BD) is a rare multisystemic inflammatory disorder.
• The potential impact of COVID-19 on autoimmune conditions like BD remains an area of active investigation.
• Identifying shared molecular pathways and biomarkers could elucidate disease mechanisms and inform therapeutic strategies.

Purpose of the Study:

• To investigate the potential role of COVID-19 in relation to Behcet's disease (BD).
• To identify common differential genes and potential biomarkers between COVID-19 and BD.
• To explore the molecular interactions and pathways linking these two conditions.

Main Methods:

• Bioinformatic analysis of RNA-sequencing data from peripheral blood mononuclear cells (PBMCs) of COVID-19 and BD patients.
• Cross-analysis to identify common up-regulated and down-regulated differential genes.
• Construction and analysis of protein-protein interaction (PPI) networks, gene-TF-miRNA networks, and gene-disease networks.

Main Results:

• Identified 461 common up-regulated and 509 common down-regulated differential genes between COVID-19 and BD.
• Highlighted 15 hub genes, including ACTB, ASPM, CCNA2, CCNB1, and CENPE, with distinct expression patterns in both diseases.
• Gene Ontology and pathway analyses indicated shared biological processes and pathways, suggesting a common association.

Conclusions:

• A significant interaction and commonality exist between COVID-19 and Behcet's disease.
• ACTB, ASPM, CCNA2, CCNB1, and CENPE are proposed as potential biomarkers for both COVID-19 and BD.
• Further research into these shared pathways may reveal novel therapeutic targets.